# Safety and Efficacy of the URECA CTO Device

> **NCT04385381** · NA · TERMINATED · sponsor: **Ureca BV** · enrollment: 11 (actual)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DEVICE:** URECA CTO device

## Key facts

- **NCT ID:** NCT04385381
- **Lead sponsor:** Ureca BV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-09-27
- **Final completion:** 2023-09-27
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** change of manufacterer of medical device
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385381, "Safety and Efficacy of the URECA CTO Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04385381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*